Cancer and HRT, When Should We Be Concerned?

Brought to you by
MediConf UK Ltd
Online course
15th May 2024
FREE
2 hrs cpd
Book this course
Cancer and HRT, When Should We Be Concerned?
Your Learning Agenda:
Based on new scientific publications, NICE guidelines, British Menopause Society statements and clinical consultations

Learning objectives

By the end of this session, you will be able to:

Describe which cancers are increased and decreased by HRT use.
Describe which cancer survivors can use HRT.
Be able to list the common prescribable non-hormonal options to treat vasomotor symptoms.
How to manage more complex cases

Course images

Agenda
15
May
Session 1
19:30 - 20:15
15
May
Break and Promotional Presentation
20:15 - 20:45
15
May
Session 2
20:45 - 21:30
15
May
Webinar Ends
21:30 - 21:30
Speakers
Dr Diana Mansour
Dr Diana Mansour is a Consultant in Community Gynaecology and Reproductive Healthcare at Newcastle upon Tyne Hospitals NHS Foundation Trust in the UK.

She is an Associate Clinical Lecturer at Newcastle University and was recently the Senior Vice President at the Faculty of Sexual and Reproductive Healthcare of the Royal College of Obstetricians and Gynaecologists. Diana currently sits on the FSRH UKMEC steering group and guideline development group. She is a British Menopause Society recogniz
Additional information
General Practice (GP)
Consultant
FIRST5 GP Group
Foundation Year Doctor
General Practitioner (Locum)
General Practitioner (Partner)
General Practitioner (Salaried)
GP Registrar
Medical Student
Pharmacist
Physician Assistant
Specialist Registrar
Specialist Trainee Doctor
Organiser reviews
No reviews for this course provider yet
Simply CPD is a product of Oppia Limited,
13 Goldhill Road
Leicester,
LE2 3LE
Built with support from: